Cargando…
The influence of Medicare Part D on the list pricing of brand drugs
OBJECTIVE: To compare the Medicare Part D market share of brand drugs with their net‐to‐list price ratio. DATA SOURCES AND STUDY SETTING: SSR Health Brand Net Price Tool and Medical Expenditure Panel Survey, 2007–2019. STUDY DESIGN: For each drug, we calculated the ratio of net to list price and the...
Autores principales: | Ippolito, Benedic N., Levy, Joseph F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315368/ https://www.ncbi.nlm.nih.gov/pubmed/36737865 http://dx.doi.org/10.1111/1475-6773.14139 |
Ejemplares similares
-
Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program
por: Socal, Mariana P., et al.
Publicado: (2021) -
Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs
por: Liu, Judith, et al.
Publicado: (2022) -
Impact of Medicare prescription drug (Part D) coverage expansion on utilisation and financial burden of benzodiazepines among older adults: an interrupted time series analysis
por: Li, Minghui, et al.
Publicado: (2021) -
Impact of the Affordable Care Act's Physician Payments Sunshine Act on branded statin prescribing
por: Li, Jing, et al.
Publicado: (2022) -
Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part D
por: Tseng, Chien-Wen, et al.
Publicado: (2020)